Abstract
AbstractHigh-throughput sequencing (HTS) is capable of broad virus detection encompassing both known and unknown adventitious viruses in a variety of sample matrices. We describe the development of a general-purpose HTS-based method for the detection of adventitious viruses. Performance was evaluated using 16 viruses equivalent to well-characterized National Institutes of Health (NIH) virus stocks and another six viruses of interest. A viral vaccine crude harvest and a cell substrate matrix were spiked with 22 viruses. Specificity was demonstrated for all 22 viruses at the species level. Our method was capable of detecting and identifying adventitious viruses spiked at 104 genome copies per milliliter in a viral vaccine crude harvest and 0.01 viral genome copies spiked per cell in a cell substrate matrix. Moreover, 9 of the 11 NIH model viruses with published in vivo data were detected by HTS with an equivalent or better sensitivity (in a viral vaccine crude harvest). Our general-purpose HTS method is unbiased and highly sensitive for the detection of adventitious viruses, and has a large breadth of detection, which may obviate the need to perform in vivo testing.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference32 articles.
1. Folb, P. I. et al. A global perspective on vaccine safety and public health: the global advisory committee on vaccine safety. Am. J. Public Health 94, 1926–1931 (2004).
2. Barone, P. W. et al. Viral contamination in biologic manufacture and implications for emerging therapies. Nat. Biotechnol. 38, 563–572 (2020).
3. Petricciani, J., Sheets, R., Griffiths, E. & Knezevic, I. Adventitious agents in viral vaccines: lessons learned from 4 case studies. Biologicals 42, 223–236 (2014).
4. World Health Organization. Scientific Principles For Regulatory Risk Evaluation On Finding An Adventitious Agent In A Marketed Vaccine (Annex 2). WHO Expert Committee on Biological Standardization. https://www.who.int/biologicals/expert_committee/TRS_978_61st_report.pdf?ua=1 (2015). (Accessed May 2019).
5. EMEA, E. M. A. ICH Topic Q5A: Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. ICH Harmonised Tripartite Guideline (2006).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献